Carlsmed, Inc. CARL

15.10 0.28 1.89% as of 25 Sep
Market cap
$404.6M
P/E
0.0×
Dec '24 Dec '25
P/E ratio
0.00 0.00
P/S ratio
1.90 3.48
P/FCF ratio
0.00 0.00
P/Operating CF
(9.45) (33.01)
P/B ratio
0.00 1.78
Price to Tangible BV
0.00 1.78
EV/Sales
1.39 1.61
EV/EBITDA
0.00 0.00
EV/Operating CF
(1.79) (2.80)
EV/FCF
(1.74) (2.67)
Quick Ratio
5.33 8.49
Current Ratio
5.60 8.87
Net Debt/EBITDA
1.03 3.12
Debt/Assets
29.74% 11.79%
Debt/Equity
0.60 0.16
Asset Turnover
0.00 0.56
Operating CF/Net income
1.02 0.96
Capex/Depreciation
(1.24) (4.83)
Interest Coverage
0.00 0.00
ROE
0.00% (214.02%)
ROA
0.00% (33.22%)
ROIC
(1,920.54%) (442.13%)
Return on Tangible Assets
(60.91%) (26.53%)
Average Days of Receivables
90.91 82.10
Research and Development Expense of Revenue
52.66% 33.69%
Selling, General and Administrative Expense of Revenue
109.94% 102.15%
Intangible Assets out of Total Assets
0.00 0.00
Share Based Compensation of Revenue
0.93% 3.82%
Graham Net Nets
0.28 0.54
Graham Number
0.00 0.00
Earnings Yield
(44.13%) (29.64%)
Free Cash Flow Yield
(41.89%) (17.27%)
Revenue per Share
6.68 3.55
Operating CF per Share
(6.26) (2.04)
Capex per Share
(0.04) (0.10)
Free Cash Flow per Share
(6.31) (2.13)
Cash per Share
9.89 7.73
Shareholders Equity per Share
6.29 6.95
Interest Debt per Share
0.00 0.00
Book value per Share
6.29 6.95
Free Cash Flow
(25.65) (30.33)
Working Capital
40.53 112.39
Capital Expenditures
(0.18) (1.36)
Net Current Asset Value
23.12 95.42
EV/EBIT
0.00 0.00
Capex to Sales
0.01 0.03
Net Profit Margin
(91.47%) (59.82%)
Price to Operating Income
0.00 0.00
Other line items
Depreciation/Fixed assets
0.56 0.19
Cash ROIC
(31.67%) (13.59%)
Accounts Receivable Turnover
0.00 5.57
Accounts Payable Turnover
0.00 3.62
Inventory Turnover
0.00 8.78
Average Days of Payables
123.70 131.15
Days of Inventory on Hand
51.03 54.00
Average Receivables
— 9.06
Average Payables
— 3.45
Average Inventory
— 1.42
Average Assets
— 90.97
Average Common Equity
— 14.12

Fold the line items

Columns are period end dates